Process for preparing solid unit dosage forms of ultra-low dose drugs

Claim 2

A process for the preparation of a solid unit dosage form, pharmaceutical composition containing an ultra-low dosage of a pharmaceutically active material, comprising the steps of: dissolving said pharmaceutically active material in a volatile inert solvent to form a dilute solution of said pharmaceutically active material; atomizing and uniformly spraying said solution in the form of fine droplets, in a small amount, over an extended time period, onto fine, inert, pharmacologically acceptable, excipient particles which are undergoing continuous agitation while in contact with surrounding gaseous medium, said excipient particles being insoluble in said solvent, and continuously evaporating said solvent and depositing large numbers of very small solid particles of said pharmaceutically active material uniformly on said excipient particles under conditions effective to prevent substantial agglomeration of said excipient particles or build-up of wetness in said excipient particles; and then forming said excipient particles containing said particles of said pharmaceutically active material into said solid unit dosage form pharmaceutical composition having an effective dosage of not more than 100 micrograms of said pharmaceutically active material per unit of said solid unit dosage form.

Claim 3

A process according to claim 1, wherein said solvent is a nonaqueous solvent having a boiling point lower than 80° C.

Claim 4

A process according to claim 1, wherein said pharmaceutically active material is dissolved in said solvent at a concentration of not greater than 10 mcg/ml, and said solution is sprayed onto said excipient particles at a rate of 1 to 10 ml/min, over a period of at least approximately ten minutes.

Claim 5

A process according to claim 1, claim 2 or claim 3, wherein said solid unit dosage form pharmaceutical composition has an effective dosage of said pharmaceutically active material of not more than 10 mcg per unit of said solid unit dosage form.

Claim 6

A process according to claim 1, claim 2 or claim 3, wherein said solvent is selected from the group consisting of methylene chloride, ethyl acetate, ethanol, methanol, fluorinated hydrocarbon compounds and mixtures thereof.

Claim 7

A process for the preparation of pharmaceutical tablets containing an ultra-low dosage of a pharmaceutically active material, which material is present as extremely fine particles in the tablets, comprising the steps of: dissolving said pharmaceutically active material in an inert, volatile, non-aqueous, organic solvent having a boiling point of less than 80° C. to form a solution containing from about 0.01 to about 10 micrograms of said pharmaceutically active material per milliliter of said solvent; atomizing and uniformly spraying said solution, in the form of fine droplets, at a rate of from about 1 to about 10 milliliters per minute, for a time period of from about 10 to about 30 minutes, onto fine, inert, pharmacologically acceptable, excipient particles which are insoluble in said solvent, are disposed in a rotating, inclined, tumbler pan and are undergoing continuous tumbling therein while in contact with a surrounding gaseous medium so that said droplets are substantially uniformly deposited on said excipient particles, and continuously slowly evaporating said solvent into said surrounding gaseous medium and thereby depositing a large number of very small solid particles of said pharmaceutically active material on said excipient particles, said particles of said pharmaceutically active material being of highly uniform size and having a maximum mean particle diameter in the range of from about 0.5 to about 10 microns whereby to provide a very low, highly uniform concentration of said pharmaceutically active material on said excipient particles, the atomizing and spraying steps being carried out under conditions effective to prevent substantial agglomeration of said excipient particles and build-up of wetness in said excipient particles; and then forming said excipient particles containing said particles of said pharmaceutically active material into tablets by the direct compression method, each of said tablets containing not more than 100 micrograms of said pharmaceutically active material.

Claim 8

A process for the preparation of pharmaceutical tablets containing an ultra-low dosage of a pharmaceutically active material, which material is present as extremely fine particles in the tablets, comprising the steps of: dissolving said pharmaceutically active material in an inert, volatile, non-aqueous, organic solvent having a boiling point of less than 80° C. to form a solution containing from about 0.01 to about 10 micrograms of said pharmaceutically active material per milliliter of said solvent; atomizing and uniformly spraying said solution, in the form of fine droplets, at a rate of from about 1 to about 10 milliliters per minute, for a time period of from about 10 to about 30 minutes, onto fine, inert, pharmacologically acceptable, excipient particles which are insoluble in said solvent, are disposed in a rotating, inclined, tumbler pan and are undergoing continuous tumbling therein while in contact with a surrounding gaseous medium so that said droplets are substantially uniformly deposited on said excipient particles, and continuously slowly evaporating said solvent into said surrounding gaseous medium and thereby depositing a large number of very small solid particles of said pharmaceutically active material on said excipient particles, said particles of said pharmaceutically active material being of highly uniform size and having a maximum mean particle diameter in the range of from about 0.5 to about 10 microns whereby to provide a very low, highly uniform concentration of said pharmaceutically active material on said excipient particles, the atomizing and spraying steps being carried out under conditions effective to prevent substantial agglomeration of said excipient particles and build-up of wetness in said excipient particles; and then forming said excipient particles containing said particles of said pharmaceutically active material into tablets by the direct compression method, each of said tablets containing not more than 100 micrograms of said pharmaceutically active material.

Claim 9

A process according to claim 6 in which said step of forming tablets is performed by placing a charge consisting essentially of said excipient particles containing said particles of said pharmaceutically active material into a die cavity, compressing said charge in said cavity between two punches to form the same into a tablet by the direct compression method effective for forming pharmaceutical tablets, and ejecting said tablet from said die cavity.